Om Research, LLC
Clinical research site in Lancaster, California
Part of Om Research
As of September 2026, 16 paid clinical trials are recruiting at Om Research, LLC in Lancaster, California. Active studies at this site cover conditions such as Irritable Bowel Syndrome, Moderately to Severely Active Crohns Disease and Ulcerative Colitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Om Research, LLC (16)
Study of DONQ52 in Active Celiac Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Get new-trial alerts for Om Research, LLC
We'll email you whenever a new clinical trial starts recruiting at this research site in Lancaster, CA. Unsubscribe anytime.
More research sites in Lancaster
- City of Hope Antelope Valley (24 trials)
- Om Research LLC (13 trials)
- Gastro Care Institute (8 trials)
- First Valley Medical Group (4 trials)
- GSK Investigational Site (3 trials)
- Chemidox Clinical Trials (3 trials)
- Akero Clinical Study Site (2 trials)
- Antelope Valley Clinical Trials (2 trials)
- Antelope Valley Medical Center (2 trials)
- Chemidox Clinical Trials Inc, Merz Investigational (2 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Lancaster, CA · California clinical trials